Structural and Functional Analysis of the CspB Protease Required for Clostridium Spore Germination

PLoS Pathogens

Volumn 9, Issue 2, 2013, Pages

  Adams, Chloe M ^a,b   Eckenroth, Brian E ^b   Putnam, Emily E ^b   Doublié, Sylvie ^b   Shen, Aimee ^b  

^a UNIVERSITY OF VERMONT   (United States)

^b UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; CSPB PROTEASE; PROTEINASE; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; CHEMICAL ANALYSIS; CLOSTRIDIUM DIFFICILE; CONTROLLED STUDY; CRYSTAL STRUCTURE; CRYSTALLIZATION; ESCHERICHIA COLI; GENETIC ANALYSIS; GERMINATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN CLEAVAGE; PROTEIN DOMAIN; PROTEIN PURIFICATION; PROTEIN STRUCTURE; SEQUENCE ANALYSIS; SPOROGENESIS; WESTERN BLOTTING;

BACTERIAL PROTEINS; CATALYTIC DOMAIN; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; CLOSTRIDIUM PERFRINGENS; HUMANS; MODELS, MOLECULAR; PEPTIDOGLYCAN; PROTEIN STRUCTURE, TERTIARY; SERINE PROTEASES; SPORES, BACTERIAL; SUBTILISIN;

EID: 84874760766     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1003165     Document Type: Article

References (70)

1. Carroll KC, Bartlett JG, (2011) Biology of Clostridium difficile: implications for epidemiology and diagnosis. Annu Rev Microbiol 65: 501-521.
2. Kelly CP, LaMont JT, (2008) Clostridium difficile-more difficult than ever. N Engl J Med 359: 1932-1940.
3. Rupnik M, Wilcox MH, Gerding DN, (2009) Clostridium difficile infection: new developments in epidemiology and pathogenesis. Nat Rev Microbiol 7: 526-536.
4. Shen A, (2012) Clostridium difficile toxins: mediators of inflammation. J Innate Immun 4: 149-158.
5. Ghantoji SS, Sail K, Lairson DR, DuPont HL, Garey KW, (2010) Economic healthcare costs of Clostridium difficile infection: a systematic review. J Hosp Infect 74: 309-318.
6. Leffler DA, Lamont JT, (2009) Treatment of Clostridium difficile-associated disease. Gastroenterology 136: 1899-1912.
7. Lawley TD, Clare S, Deakin LJ, Goulding D, Yen JL, et al. (2010) Use of purified Clostridium difficile spores to facilitate evaluation of health care disinfection regimens. Appl Environ Microbiol 76: 6895-6900.
8. Leggett MJ, McDonnell G, Denyer SP, Setlow P, Maillard JY, (2012) Bacterial spore structures and their protective role in biocide resistance. J Appl Microbiol 113: 485-498.
9. Setlow P, (2006) Spores of Bacillus subtilis: their resistance to and killing by radiation, heat and chemicals. J Appl Microbiol 101: 514-525.
10. Deakin LJ, Clare S, Fagan RP, Dawson LF, Pickard DJ, et al. (2012) The Clostridium difficile spo0A gene is a persistence and transmission factor. Infect Immun 80: 2704-2711.
11. Maroo S, Lamont JT, (2006) Recurrent Clostridium difficile. Gastroenterology 130: 1311-1316.
12. Burns DA, Heap JT, Minton NP, (2010) Clostridium difficile spore germination: an update. Res Microbiol 161: 730-734.
13. Paredes-Sabja D, Setlow P, Sarker MR, (2011) Germination of spores of Bacillales and Clostridiales species: mechanisms and proteins involved. Trends Microbiol 19: 85-94.
14. Setlow P, (2003) Spore germination. Curr Opin Microbiol 6: 550-6.
15. Giel JL, Sorg JA, Sonenshein AL, Zhu J, (2010) Metabolism of bile salts in mice influences spore germination in Clostridium difficile. PLoS One 5: e8740.
16. Sorg JA, Sonenshein AL, (2008) Bile salts and glycine as cogerminants for Clostridium difficile spores. J Bacteriol 190: 2505-2512.
17. Sorg JA, Sonenshein AL, (2010) Inhibiting the initiation of Clostridium difficile spore germination using analogs of chenodeoxycholic acid, a bile acid. J Bacteriol 192: 4983-4990.
18. Moir A, (2006) How do spores germinate? J Appl Microbiol 101: 526-530.
19. Burns DA, Heap JT, Minton NP, (2010) SleC is essential for germination of Clostridium difficile spores in nutrient-rich medium supplemented with the bile salt taurocholate. J Bacteriol 192: 657-664.
20. Paredes-Sabja D, Setlow P, Sarker MR, (2009) SleC is essential for cortex peptidoglycan hydrolysis during germination of spores of the pathogenic bacterium Clostridium perfringens. J Bacteriol 191: 2711-2720.
21. Miyata S, Moriyama R, Miyahara N, Makino S, (1995) A gene (sleC) encoding a spore-cortex-lytic enzyme from Clostridium perfringens S40 spores; cloning, sequence analysis and molecular characterization. Microbiology 141 (Pt 10) (): 2643-2650.
22. Miyata S, Moriyama R, Sugimoto K, Makino S, (1995) Purification and partial characterization of a spore cortex-lytic enzyme of Clostridium perfringens S40 spores. Biosci Biotechnol Biochem 59: 514-515.
23. Okamura S, Urakami K, Kimata M, Aoshima T, Shimamoto S, et al. (2000) The N-terminal prepeptide is required for the production of spore cortex-lytic enzyme from its inactive precursor during germination of Clostridium perfringens S40 spores. Mol Microbiol 37: 821-827.
24. Urakami K, Miyata S, Moriyama R, Sugimoto K, Makino S, (1999) Germination-specific cortex-lytic enzymes from Clostridium perfringens S40 spores: time of synthesis, precursor structure and regulation of enzymatic activity. FEMS Microbiol Lett 173: 467-473.
25. Shimamoto S, Moriyama R, Sugimoto K, Miyata S, Makino S, (2001) Partial characterization of an enzyme fraction with protease activity which converts the spore peptidoglycan hydrolase (SleC) precursor to an active enzyme during germination of Clostridium perfringens S40 spores and analysis of a gene cluster involved in the activity. J Bacteriol 183: 3742-3751.
26. Paredes-Sabja D, Setlow P, Sarker MR, (2009) The protease CspB is essential for initiation of cortex hydrolysis and dipicolinic acid (DPA) release during germination of spores of Clostridium perfringens type A food poisoning isolates. Microbiology 155: 3464-3472.
27. Cartman ST, Minton NP, (2010) A mariner-based transposon system for in vivo random mutagenesis of Clostridium difficile. Appl Environ Microbiol 76: 1103-1109.
28. Rawlings N, Barrett A, Bateman A, (2012) MEROPS: the database of proteolytic enzymes, their substrates and inhibitors. Nucl Acids Res 40: 50.
29. Siezen RJ, Leunissen JA, (1997) Subtilases: the superfamily of subtilisin-like serine proteases. Protein Sci 6: 501-523.
30. Shinde U, Inouye M, (2000) Intramolecular chaperones: polypeptide extensions that modulate protein folding. Semin Cell Dev Biol 11: 35-44.
31. Shinde U, Thomas G, (2011) Insights from bacterial subtilases into the mechanisms of intramolecular chaperone-mediated activation of furin. Methods Mol Biol 768: 59-106.
32. Heap JT, Pennington OJ, Cartman ST, Carter GP, Minton NP, (2007) The ClosTron: a universal gene knock-out system for the genus Clostridium. J Microbiol Methods 70: 452-464.
33. Heap JT, Pennington OJ, Cartman ST, Minton NP, (2009) A modular system for Clostridium shuttle plasmids. J Microbiol Methods 78: 79-85.
34. Schechter I, Berger A, (2012) On the size of the active site in proteases. I. Papain. 1967. Biochem Biophys Res Commun 425: 497-502.
35. Foophow T, Tanaka S, Angkawidjaja C, Koga Y, Takano K, et al. (2010) Crystal structure of a subtilisin homologue, Tk-SP, from Thermococcus kodakaraensis: requirement of a C-terminal beta-jelly roll domain for hyperstability. J Mol Biol 400: 865-877.
36. Holm L, Sander C, (1995) Dali: a network tool for protein structure comparison. Trends Biochem Sci 20: 478-480.
37. Comellas-Bigler M, Maskos K, Huber R, Oyama H, Oda K, et al. (2004) 1.2 A crystal structure of the serine carboxyl proteinase pro-kumamolisin; structure of an intact pro-subtilase. Structure 12: 1313-1323.
38. Gallagher T, Gilliland G, Wang L, Bryan P, (1995) The Prosegment-Subtilisin Bpn Complex- Crystal-Structure of a Specific Foldase. Structure 3: 907-914.
39. Jain SC, Shinde U, Li Y, Inouye M, Berman HM, (1998) The crystal structure of an autoprocessed Ser221Cys-subtilisin E-propeptide complex at 2.0 A resolution. J Mol Biol 284: 137-144.
40. Tanaka S, Matsumura H, Koga Y, Takano K, Kanaya S, (2007) Four new crystal structures of Tk-subtilisin in unautoprocessed, autoprocessed and mature forms: insight into structural changes during maturation. J Mol Biol 372: 1055-1069.
41. Tanaka S, Saito K, Chon H, Matsumura H, Koga Y, et al. (2007) Crystal structure of unautoprocessed precursor of subtilisin from a hyperthermophilic archaeon: evidence for Ca2+-induced folding. J Biol Chem 282: 8246-8255.
42. Seidah NG, Prat A, (2012) The biology and therapeutic targeting of the proprotein convertases. Nat Rev Drug Discov 11: 367-383.
43. Cunningham D, Danley DE, Geoghegan KF, Griffor MC, Hawkins JL, et al. (2007) Structural and biophysical studies of PCSK9 and its mutants linked to familial hypercholesterolemia. Nat Struct Mol Biol 14: 413-419.
44. Hampton EN, Knuth MW, Li J, Harris JL, Lesley SA, et al. (2007) The self-inhibited structure of full-length PCSK9 at 1.9 A reveals structural homology with resistin within the C-terminal domain. Proc Natl Acad Sci U S A 104: 14604-14609.
45. Piper DE, Jackson S, Liu Q, Romanow WG, Shetterly S, et al. (2007) The crystal structure of PCSK9: a regulator of plasma LDL-cholesterol. Structure 15: 545-552.
46. Krissinel E, Henrick K, (2007) Inference of macromolecular assemblies from crystalline state. J Mol Biol 372: 774-797.
47. Simon GM, Cravatt BF, (2010) Activity-based proteomics of enzyme superfamilies: serine hydrolases as a case study. J Biol Chem 285: 11051-11055.
48. Seidah NG, (2011) The proprotein convertases, 20 years later. Methods Mol Biol 768: 23-57.
49. Gluschankof P, Fuller RS, (1994) A C-Terminal Domain Conserved in Precursor Processing Proteases Is Required for Intramolecular N-Terminal Maturation of Pro-Kex2 Protease. Embo Journal 13: 2280-2288.
50. Henrich S, Lindberg I, Bode W, Than ME, (2005) Proprotein convertase models based on the crystal structures of furin and kexin: explanation of their specificity. J Mol Biol 345: 211-227.
51. Holyoak T, Wilson MA, Fenn TD, Kettner CA, Petsko GA, et al. (2003) 2.4 Å resolution crystal structure of the prototypical hormone-processing protease Kex2 in complex with an Ala-Lys-Arg boronic acid inhibitor. Biochemistry 42: 6709-6718.
52. Benjannet S, Hamelin J, Chretien M, Seidah NG, (2012) Loss- and gain-of-function PCSK9 variants: cleavage specificity, dominant negative effects, and low density lipoprotein receptor (LDLR) degradation. J Biol Chem 287: 33745-33755.
53. Burri DJ, Pasqual G, Rochat C, Seidah NG, Pasquato A, et al. (2012) Molecular characterization of the processing of arenavirus envelope glycoprotein precursors by subtilisin kexin isozyme-1/site-1 protease. J Virol 86: 4935-4946.
54. Chang YS, Liaw SH, Mei HC, Hsu CC, Wu CY, et al. (2002) Mutational analysis of the autoprocessing site of subtilisin YaB-G124A. Biochem Biophys Res Commun 291: 165-169.
55. Mayne J, Dewpura T, Raymond A, Bernier L, Cousins M, et al. (2011) Novel loss-of-function PCSK9 variant is associated with low plasma LDL cholesterol in a French-Canadian family and with impaired processing and secretion in cell culture. Clin Chem 57: 1415-1423.
56. Takahashi M, Hasuura Y, Nakamori S, Takagi H, (2001) Improved autoprocessing efficiency of mutant subtilisins E with altered specificity by engineering of the pro-region. J Biochem 130: 99-106.
57. O'Connor JR, Lyras D, Farrow KA, Adams V, Powell DR, et al. (2006) Construction and analysis of chromosomal Clostridium difficile mutants. Mol Microbiol 61: 1335-1351.
58. Sebaihia M, Wren BW, Mullany P, Fairweather NF, Minton N, et al. (2006) The multidrug-resistant human pathogen Clostridium difficile has a highly mobile, mosaic genome. Nat Genet 38: 779-786.
59. Sorg JA, Dineen SS, (2009) Laboratory maintenance of Clostridium difficile. Curr Protoc Microbiol Chapter 9: Unit9A 1.
60. Dubberke ER, Olsen MA, (2012) Burden of Clostridium difficile on the healthcare system. Clin Infect Dis 55 Suppl 2: S88-92.
61. Permpoonpattana P, Tolls EH, Nadem R, Tan S, Brisson A, et al. (2011) Surface layers of Clostridium difficile endospores. J Bacteriol 193: 6461-6470.
62. Kantardjieff KA, Rupp B, (2003) Matthews coefficient probabilities: Improved estimates for unit cell contents of proteins, DNA, and protein-nucleic acid complex crystals. Protein Sci 12: 1865-1871.
63. Matthews BW, (1968) Solvent content of protein crystals. J Mol Biol 33: 491-497.
64. Winn MD, Ballard CC, Cowtan KD, Dodson EJ, Emsley P, et al. (2011) Overview of the CCP4 suite and current developments. Acta Crystallogr D Biol Crystallogr 67: 235-242.
65. Otwinowski Z, Minor W, (1997) Macromolecular Crystallography, Part A. Methods in Enzymology 276: 307-326.
66. Sheldrick GM, (2010) Experimental phasing with SHELXC/D/E: combining chain tracing with density modification. Acta Crystallogr D Biol Crystallogr 66: 479-485.
67. Debreczeni JE, Bunkoczi G, Ma Q, Blaser H, Sheldrick GM, (2003) In-house measurement of the sulfur anomalous signal and its use for phasing. Acta Crystallogr D Biol Crystallogr 59: 688-696.
68. Adams PD, Afonine PV, Bunkoczi G, Chen VB, Davis IW, et al. (2010) PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr D Biol Crystallogr 66: 213-221.
69. Emsley P, Lohkamp B, Scott WG, Cowtan K, (2010) Features and development of Coot. Acta Crystallogr D Biol Crystallogr 66: 486-501.
70. Myers GS, Rasko DA, Cheung JK, Ravel J, Seshadri R, et al. (2006) Skewed genomic variability in strains of the toxigenic bacterial pathogen, Clostridium perfringens. Genome Res 16: 1031-1040.